As of 04 Nov 2026 18:08 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2023/079 (22 Aug 2023): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Minims® Oxybuprocaine hydrochloride 0.4% eye drops 0.5ml unit dose and Minims® Proxymetacaine 0.5% eye drops 0.5ml unit doseaffected product · inferred from phrasing | Limited supply, as stated | early October 2023precision: early in the month · window end 10 Oct 2023, derived from “early October 2023” | notice of 22 Aug 2023 |
| Minims® Tetracaine Hydrochloride 0.5% w/v and 1% w/v eye drop solutionnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 22 Aug 2023 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Minims® Tetracaine Hydrochloride 0.5% w/v and 1% w/v eye drop solution — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Minims Oxybuprocaine Hydrochloride
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 22 Aug 2023. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 22 Aug 2023 | Medicine Supply Notification: Minims® Oxybuprocaine hydrochloride 0.4% eye drops 0.5ml unit dose Minims® Proxymetacaine 0.5% eye drops 0.5ml unit dose | Supply notification | Tier 3 | MSN/2023/079 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
No NHS Scotland Medicine Supply Alert Notice on record matches this name. Scotland is a separate record (all Scotland alerts); absence here is not a statement about supply in Scotland.